Patents by Inventor Gopal Rajan Ranga Rajan

Gopal Rajan Ranga Rajan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220008333
    Abstract: The present invention is concerned with dispersible compositions comprising rilpivirine or a pharmaceutically acceptable acid addition salt thereof as an active ingredient. Such compositions are useful in the treatment of HIV infection and their dispersibility properties lend themselves to be useful in particular amongst the pediatric or geriatric population.
    Type: Application
    Filed: June 15, 2021
    Publication date: January 13, 2022
    Inventors: Harshad Patankar, Nicolaas Martha Felix Goyvaerts, Gopal Rajan Ranga Rajan
  • Patent number: 11065198
    Abstract: The present invention is concerned with dispersible compositions comprising rilpivirine or a pharmaceutically acceptable acid addition salt thereof as an active ingredient. Such compositions are useful in the treatment of HIV infection and their dispersibility properties lend themselves to be useful in particular amongst the pediatric or geriatric population.
    Type: Grant
    Filed: October 23, 2017
    Date of Patent: July 20, 2021
    Assignee: Janssen Sciences Ireland Unlimited Company
    Inventors: Harshad Patankar, Nicolaas Martha Felix Goyvaerts, Gopal Rajan Ranga Rajan
  • Publication number: 20200397784
    Abstract: The present invention relates to pharmaceutical compositions, each comprising a multitude of granules that make up an intragranular phase of the composition, wherein the granules are produced by fluid bed granulation and comprise a HCl salt of Compound (1).xH2O wherein x is from 0 to 3, and one or more excipients selected from a disintegrant, a binder, and a wetting agent. The pharmaceutical composition also comprises one or more excipients that make up an extragranular phase of the composition, selected from a diluent, a disintegrant, a glidant, and a lubricant. The invention also relates to processes for producing the pharmaceutical compositions of the invention. The invention further relates to uses and methods of the pharmaceutical compositions in reducing the amount of influenza viruses in a biological in vitro sample or in a subject, inhibiting the replication of influenza viruses in a biological in vitro sample or in a subject, and treating influenza in a subject.
    Type: Application
    Filed: April 17, 2020
    Publication date: December 24, 2020
    Inventors: Gopal Rajan Ranga Rajan, Geert Van Der Avoort, Rudolf Josephus Dijmphna Leemans
  • Publication number: 20200069579
    Abstract: The present invention is concerned with dispersible compositions comprising rilpivirine or a pharmaceutically acceptable acid addition salt thereof as an active ingredient. Such compositions are useful in the treatment of HIV infection and their dispersibility properties lend themselves to be useful in particular amongst the pediatric or geriatric population.
    Type: Application
    Filed: October 23, 2017
    Publication date: March 5, 2020
    Inventors: Harshad Patankar, Nicolaas Martha Felix Goyvaerts, Gopal Rajan Ranga Rajan